🇺🇸 FDA
Patent

US 10233191

Fused piperidine amides as modulators of ion channels

granted A61PA61P25/04A61P43/00

Quick answer

US patent 10233191 (Fused piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P25/04, A61P43/00